Tanaka, R., Tomosugi, M., Horinaka, M., Sowa, Y., & Sakai, T. (2015). Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. PLoS One.

Tanaka, Ryoichi, Mitsuhiro Tomosugi, Mano Horinaka, Yoshihiro Sowa, και Toshiyuki Sakai. "Metformin Causes G1-Phase Arrest Via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity Through DR5 Up-Regulation in Pancreatic Cancer Cells." PLoS One 2015.

Tanaka, Ryoichi, et al. "Metformin Causes G1-Phase Arrest Via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity Through DR5 Up-Regulation in Pancreatic Cancer Cells." PLoS One 2015.